1. Home
  2. FOFO vs HBIO Comparison

FOFO vs HBIO Comparison

Compare FOFO & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FOFO

Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

HOLD

Current Price

$2.37

Market Cap

29.7M

Sector

N/A

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$5.29

Market Cap

24.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOFO
HBIO
Founded
2017
1901
Country
Hong Kong
United States
Employees
14
339
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
29.7M
24.9M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
FOFO
HBIO
Price
$2.37
$5.29
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.00
AVG Volume (30 Days)
60.1K
36.7K
Earning Date
03-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$116,176,000.00
Revenue This Year
N/A
$4.77
Revenue Next Year
N/A
$8.55
P/E Ratio
$11.09
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.30
$0.28
52 Week High
$68.00
$7.50

Technical Indicators

Market Signals
Indicator
FOFO
HBIO
Relative Strength Index (RSI) 32.42 42.60
Support Level $2.34 $4.42
Resistance Level $5.74 $5.79
Average True Range (ATR) 0.31 0.45
MACD -0.01 -0.27
Stochastic Oscillator 6.73 1.33

Price Performance

Historical Comparison
FOFO
HBIO

About FOFO Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their unique business and investment objectives. Its business consists of two main segments: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting, and Regulatory compliance and governance consulting.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Share on Social Networks: